Inhibiting the IRE1α/XBP1 axis with Z4P enhances temozolomide efficacy in glioblastoma [145], while 4μ8C and STF-083010 potentiate 5-fluorouracil in colorectal cancer [146] and show strong anti-myeloma activity [147]. Here, XBP1 is linked to plasma cell myeloma.